NEPT - Neptune Technologies & Bioressources Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
3.05
-0.05 (-1.61%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close3.10
Open3.13
Bid2.90 x 2900
Ask3.14 x 1100
Day's Range3.01 - 3.15
52 Week Range0.80 - 4.46
Volume528,277
Avg. Volume969,381
Market Cap243.994M
Beta1.49
PE Ratio (TTM)18.48
EPS (TTM)0.17
Earnings DateJan 10, 2017 - Jan 16, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2008-07-24
1y Target Est3.15
Trade prices are not sourced from all markets
  • CNW Group3 days ago

    Neptune Announces Appointment of Hélène F. Fortin to its Board of Directors

    LAVAL, QC , Aug. 16, 2018 /CNW Telbec/ - Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NEPT) (NEPT.TO) announces the appointment of Ms. Hélène F. Fortin to its Board of Directors. "We are pleased that Ms. Fortin has accepted to join the Board of Neptune," said John Moretz , Chairman. A member of CPA Québec, she lectured in Accounting and Auditing during more than 20 years at many universities in both the undergraduate and graduate levels.

  • PR Newswire3 days ago

    Neptune Announces Appointment of Hélène F. Fortin to its Board of Directors

    LAVAL, QC, Aug. 16, 2018 /PRNewswire/ - Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NEPT) (NEPT.TO) announces the appointment of Ms. Hélène F. Fortin to its Board of Directors. "We are pleased that Ms. Fortin has accepted to join the Board of Neptune," said John Moretz, Chairman. A member of CPA Québec, she lectured in Accounting and Auditing during more than 20 years at many universities in both the undergraduate and graduate levels.

  • CNW Group3 days ago

    Neptune Announces the Election of its Directors and Voting Results

    Neptune Announces the Election of its Directors and Voting Results

  • PR Newswire3 days ago

    Neptune Announces the Election of its Directors and Voting Results

    LAVAL, QC , Aug. 15, 2018 /PRNewswire/ - Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT), announces  the voting results for the matters listed ...

  • ACCESSWIRE4 days ago

    Neptune Technologies & Bioressources Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 15, 2018 / Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT ) will be discussing their earnings results in their Q1 Earnings Call to be held on August 15, 2018 ...

  • Associated Press4 days ago

    Neptune Tech: Fiscal 1Q Earnings Snapshot

    On a per-share basis, the Laval, Quebec-based company said it had a loss of 4 cents. The krill oil maker posted revenue of $4 million in the period. In the final minutes of trading on Tuesday, the company's ...

  • CNW Group4 days ago

    Neptune Announces First Quarter Results

    Neptune Announces First Quarter Results

  • PR Newswire4 days ago

    Neptune Announces First Quarter Results

      Phase I Investment of the Cannabis Business Plan Completed   And Phase II capacity expansion ongoing Q1 Financial and Operational Highlights for the 3-month period ended June 30, 2018 compared to the ...

  • Why Neptune Technologies & Bioressources Inc’s (TSE:NEPT) Investor Composition Impacts Your Returns
    Simply Wall St.4 days ago

    Why Neptune Technologies & Bioressources Inc’s (TSE:NEPT) Investor Composition Impacts Your Returns

    Today, I will be analyzing Neptune Technologies & Bioressources Inc’s (TSE:NEPT) recent ownership structure, an important but not-so-popular subject among individual investors. Ownership structure has been found to have anRead More...

  • PR Newswire10 days ago

    Neptune Files Two Patent Applications for Innovative Cannabis Extraction Processes

    LAVAL, QC, Aug. 9, 2018 /PRNewswire/ - Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (NEPT.TO) has filed two applications with the United States Patent and Trademark Office (USPTO) for patents related to the extraction of cannabis material. The extraction processes provide highly-efficient methods to obtain cannabinoids and other desired compounds from the cannabis plant at a greater purity than conventional methods. Both processes are applicable to marijuana and hemp and will be incorporated into the company's Good Manufacturing Practices (GMP)-certified extraction facility in Sherbrooke, QC upon approval of the applicable licensing to produce cannabis extract (pursuant to the Access to Cannabis for Medical Purposes Regulations).  As a late-stage applicant, Neptune is currently working with Health Canada authorities to complete the licensing process.

  • CNW Group10 days ago

    Neptune Files Two Patent Applications for Innovative Cannabis Extraction Processes

    LAVAL, QC , Aug. 9, 2018 /CNW Telbec/ - Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (NEPT.TO) has filed two applications with the United States Patent and Trademark Office (USPTO) for patents related to the extraction of cannabis material. The extraction processes provide highly-efficient methods to obtain cannabinoids and other desired compounds from the cannabis plant at a greater purity than conventional methods. Both processes are applicable to marijuana and hemp and will be incorporated into the company's Good Manufacturing Practices (GMP)-certified extraction facility in Sherbrooke, QC upon approval of the applicable licensing to produce cannabis extract (pursuant to the Access to Cannabis for Medical Purposes Regulations).  As a late-stage applicant, Neptune is currently working with Health Canada authorities to complete the licensing process.

  • CNW Group11 days ago

    Perceptive Advisors, LLC inceases its position in Neptune Technologies & Bioressources Inc.

    NEW YORK , Aug. 7, 2018 /CNW Telbec/ - Perceptive Advisors, LLC ("Perceptive Advisors") announces that on December 14, 2017 it acquired, on behalf of certain fund accounts it manages, 200,000 common shares (the "Initial Shares") of Neptune Technologies & Bioressources Inc. ("Neptune") (NEPT.TO) (NEPT), representing approximately 0.25% of the issued and outstanding common shares of Neptune. Immediately prior to the acquisition, Perceptive Advisors owned 7,850,315 common shares representing approximately 9.91% of the issued and outstanding common shares of Neptune. This acquisition increased Perceptive Advisors' position in the common shares of Neptune to 8,050,315, or approximately 10.16% of the issued and outstanding common shares.

  • PR Newswire18 days ago

    Neptune to Hold Conference Call to Discuss First Quarter Results for the Three Months Period Ended June 30, 2018

    LAVAL, QC , July 31, 2018 /PRNewswire/ - Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT), announces that it will be holding a conference ...

  • CNW Group18 days ago

    Neptune to Hold Conference Call to Discuss First Quarter Results for the Three Months Period Ended June 30, 2018

    Neptune to Hold Conference Call to Discuss First Quarter Results for the Three Months Period Ended June 30, 2018

  • Investopedia18 days ago

    Penny Stocks to Watch for August 2018

    Penny stock pickers booked modest returns in these tough conditions, while trend followers and dart throwers took losses. The July penny stock list generated mixed returns, with precious metals and biotech headwinds limiting gains while a mid-month crude oil reversal undermined small energy plays.

  • ACCESSWIRE25 days ago

    Breakfast Technical Briefing on Neptune Technologies & Bioressources and Three Other Additional Biotech Stocks

    LONDON, UK / ACCESSWIRE / July 25, 2018 / If you want a free Stock Review on NEPT sign up now at www.wallstequities.com/registration. Under evaluation this morning are the following equities: Magenta Therapeutics Inc. (MGTA), Matinas BioPharma Holdings Inc. (NYSE AMER: MTNB), MyoKardia Inc. (NASDAQ: MYOK), and Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT).

  • How to make, and avoid losing, money with marijuana stocks
    MarketWatch25 days ago

    How to make, and avoid losing, money with marijuana stocks

    This is an instructive tale of how some investors with the right knowledge just made good money in three marijuana stocks, while others with less knowledge lost money in two marijuana stocks and missed the opportunity to buy the third. To make money in marijuana stocks, investors need to understand the true nature of the companies and the stocks, and have available to them expert guidance. Please click here for an annotated chart of marijuana stock Canopy Growth (CGC) For the sake of full transparency, this is exactly the same chart that was published previously.

  • Tilray’s IPO is creating a buzz, but don’t overspend on marijuana stocks
    MarketWatch29 days ago

    Tilray’s IPO is creating a buzz, but don’t overspend on marijuana stocks

    Valuations today are very high and sentiment is very positive — a bad combination, says Nigam Arora.

  • Harry Boxer’s four health-care stocks to watch
    MarketWatchlast month

    Harry Boxer’s four health-care stocks to watch

    In focus: Arbutus Biopharma, Marinus Pharmaceuticals, Neptune Technologies & Bioressources and OPKO Health.

  • MarketWatch2 months ago

    Investors are making stoner moves by buying marijuana stocks at the wrong time

    The average investor is pouring money into the stocks while professionals are dumping themParamount PicturesDon’t let marijuana stocks go up in smoke. Mom-and-pop investors have become excited about the use of marijuana and cannabis. Unfortunately, those investors have not had the proper guidance or expertise about when and how to buy marijuana stocks.

  • InvestorPlace2 months ago

    Marijuana Stocks: Two to Consider, Two to Avoid

    The marijuana legalization movement is picking up speed. Uruguay became the first nation in the Americas to permit recreational marijuana usage in 2014. Marijuana stocks were waiting for a bigger market to come online.

  • What Are Neptune’s Key Growth Strategies for Fiscal 2019?
    Market Realist2 months ago

    What Are Neptune’s Key Growth Strategies for Fiscal 2019?

    Neptune Technologies and Bioressources (NEPT) is based in Quebec, Canada. The company develops various turnkey solutions and offers specialty ingredients that include the MaxSimil and Biodroga nutrition business. The below diagram shows the highlights of Neptune’s performance in fiscal 2018.

  • Neptune Stock Rises on Multiyear Contract with Canopy Growth
    Market Realist2 months ago

    Neptune Stock Rises on Multiyear Contract with Canopy Growth

    Over the last one week, Neptune Technologies and Bioressources (NEPT) has risen ~94%. The rise in the company’s stock was triggered by the news of the company entering a multiyear agreement with Canopy Growth (CGC) to supplement its extraction, refinement, and extract product formulation capacity. The agreement could advance Neptune’s aim to expand its footprint in the cannabis industry.

  • Analysts See Upside of 35% for Neptune for Next 12 Months
    Market Realist2 months ago

    Analysts See Upside of 35% for Neptune for Next 12 Months

    Neptune Technologies and Bioressources (NEPT) is a wellness product company based in Quebec, Canada. With the legalization of cannabis in Canada, the company has been making big plans to expand in the cannabis market and leverage its scientific and technological expertise to expand across this potential growth market. Some of the largest players in this segment include Aurora Cannabis (ACB), Canopy Growth (CGC), and MedReleaf (MEDFF), which saw their stock prices rise during the first week of June when the Cannabis Act was approved in Canada. ...

  • Here's Why Neptune Technologies & Bioressources Rose as Much as 23.8% Today
    Motley Fool2 months ago

    Here's Why Neptune Technologies & Bioressources Rose as Much as 23.8% Today

    The marijuana stock is now up 353% in the last year.